Fibrocystic Disease of Breast Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Multicenter Evaluation of the Use of Topically Administered Danazol Versus Placebo in Subjects With Pain Associated With Fibrocystic Breast Disease
The purpose of this study is to determine the safety of three doses of topically applied danazol compared to placebo in subjects with pain associated with fibrocystic breast disease and to determine the appropriate clinical dose for future studies.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02929420 -
A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule
|
Phase 4 | |
| Withdrawn |
NCT00310882 -
Involvement of Endogenous Digitalis-like Compounds in Breast Cancer
|
N/A | |
| Completed |
NCT00826488 -
A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses
|
Phase 0 | |
| Active, not recruiting |
NCT00237523 -
Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain
|
Phase 3 | |
| Completed |
NCT00999921 -
Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer
|
Phase 4 |